ASH

Thank you for attending our Working Dinner and Poster Session at ASH 2018! 

 

Each annual working dinner has been an amazing opportunity for the international community of Castleman disease physicians and researchers to come together to discuss key CDCN priorities focused on patient care and the international research agenda. The CDCN looks forward to continuing the conversation and pushing forward our efforts to defeat Castleman disease every year. 

Please check back in Fall 2019 for updates regarding our 2019 Working Dinner Meeting and Poster Session. You can read about our experience at ASH 2018 here and see details from our ASH 2018 events below!

CDCN/Castleman Disease Research and Education at ASH 2018
 

Saturday, December 1, 2018

  1. 9:30 - 11:00AM: ASH General Education Session: "Anxiety-Provoking Consults: Macrophage Activation Syndrome, Castleman Disease, and Hypereosinophilia," presentation on CD by David Fajgenbaum (Manchester Grand Hyatt San Diego, Grand Hall D)

  2. 4:00 - 5:30PM: ASH General Education Session: "Anxiety-Provoking Consults: Macrophage Activation Syndrome, Castleman Disease, and Hypereosinophilia," presentation on CD by David Fajgenbaum (Manchester Grand Hyatt San Diego, Grand Hall D)

  3. 6:15 - 8:15PM: ASH Poster Presentation: PI3K/Akt/mTOR pathway activity is increased in lymph node tissue from idiopathic multicentric Castleman disease patients with TAFRO syndrome" (Session 203, Abstract# 1121, San Diego Convention Center, Hall GH)

  4. 6:30 - 7:30PM: CDCN's pre-Working Dinner Meeting: “Drinks and Data” poster session (Hard Rock Hotel, Legends 6) 

  5. 7:30 - 9:30PM: CDCN's 7th Annual “Accelerating Research & Treatments for Castleman Disease" Working Dinner Meeting (Hard Rock Hotel, Legends 6) 

Sunday, December 2, 2018

  1. 6:00 - 8:00PM: ASH Poster Presentation: Single-Cell RNA-Sequencing of Peripheral Blood Mononuclear Cells Reveals Changes in Immune Cell Composition and Distinct Inflammatory Gene Expression Profiles during Idiopathic Multicentric Castleman Disease Flare (Session 203, Abstract# 2406, San Diego Convention Center, Hall GH)

  2. 6:00 - 8:00PM: ASH Poster Presentation: Oligoclonal expansion of CD8+ T cells during idiopathic multicentric Castleman disease flares suggests an antigen driven process (Session 203, Abstract# 2411, San Diego Convention Center, Hall GH)

 Monday, December 3, 2018

  1. 6:00 - 8:00PM: ASH Poster Presentation: Serum proteomics reveals distinct subtypes associated with treatment response in idiopathic multicentric Castleman disease (Session 203, Abstract# 3716, San Diego Convention Center, Hall GH)

  2. 6:00 - 8:00PM: ASH Poster Presentation: "Hypercytokine-producing cells and oligoclonal T-cell populations in lymph nodes from Castleman disease patients" (Session 203, Abstract# 3725, San Diego Convention Center, Hall GH)

  3. 6:00 - 8:00PM: ASH Poster Presentation: "A Prospective Phase II Study of Thalidomide, Cyclophosphamide and Prednisone in Newly Diagnosed Idiopathic Multicentric Castleman's Disease" (Session 203, Abstract# 4142, San Diego Convention Center, Hall GH)
History: The CDCN held its first "Accelerating research & treatment for Castleman disease" meeting at the American Society of Hematology (ASH) 2012 meeting in Atlanta, GA. Thirty physicians, physician-scientists, and pharmaceutical partners from around the world joined us to share the latest discoveries around Castleman disease, which demonstrated clinician interest, determined initial priorities, and built tremendous momentum for the CDCN. Each year since, the CDCN's annual working dinner has been attended by more than 50 physicians and researchers, truly representing the incredible community of global experts dedicated to advancing the understanding and management of Castleman disease. 

Abstracts from four posters presentated at last year's annual working dinner meeting in Atlanta, GA can be found below:

Sponsorship: Janssen Pharmaceuticals has generously sponsored this year's Working Dinner meeting! We are grateful for their support of the CD community.